Login to Your Account



GSK, Emory Initiatives Address Translational Science Flaws

By Marie Powers
BioWorld Today Staff Writer



Monday, June 17, 2013

Two initiatives from different ends of the drug development spectrum are shining a bright light on nagging weaknesses in translational medicine and the urgent need to improve speed and efficiency in moving early stage discoveries into therapeutic candidates.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription